Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -1166.32x as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1166.32x.
INTEREST COVERAGE RATIO
-1166.32x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
-79.54x
INTEREST COVERAGE RATIO AVG 15Y
-20.49x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-1366.40%
CURRENT VS 15Y AVG
-5591.15%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-18010.55%
vs the sector median at left
Processa Pharmaceuticals, Inc.
Market Cap
$4.21M
Interest Coverage Ratio
-1166.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.32M
Interest Coverage Ratio
-21.32x
TTM Avg
128.62x
3Y Avg
128.62x
5Y Avg
128.62x
Market Cap
$4.40M
Interest Coverage Ratio
-765.53x
TTM Avg
1.76x
3Y Avg
1.76x
5Y Avg
1.76x
Market Cap
$3.93M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.90M
Interest Coverage Ratio
-994.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.53M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.69M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | $4.21M | -1166.32x | N/A | N/A | N/A |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | N/A | N/A | N/A |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -21.32x | 128.62x | 128.62x | 128.62x |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.40M | -765.53x | 1.76x | 1.76x | 1.76x |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | N/A | N/A | N/A | N/A |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -994.05x | N/A | N/A | N/A |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.53M | N/A | N/A | N/A | N/A |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | N/A | N/A | N/A | N/A |
| CalciMedica, Inc. (CALC)vs › | $4.69M | -16.26x | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $4.71M | N/A | 1.00x | 1.02x | 1.02x |
Interest Coverage
-1166.3x
Debt/Equity
N/A
Current Ratio
0.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1166.32x |
| 2021-03-31 | -6058.86x |
| 2020-12-31 | -177.78x |
| 2020-09-30 | -15.87x |
| 2020-06-30 | -41.60x |
| 2020-03-31 | -57.43x |
| 2019-12-31 | -38.50x |
| 2019-09-30 | -442.10x |
| 2019-06-30 | -186.33x |
| 2019-03-31 | -191.85x |
| 2018-12-31 | -108.66x |
| 2018-09-30 | -127.71x |
| 2018-06-30 | -24.49x |
| 2018-03-31 | -14.72x |
| 2017-09-30 | -3.71x |
| 2017-06-30 | -0.16x |
| 2017-03-31 | -0.22x |
| 2016-12-31 | -0.28x |
| 2016-09-30 | -0.08x |
| 2016-06-30 | -0.14x |
| 2016-03-31 | -1.35x |
| 2015-12-31 | -1.26x |
| 2015-09-30 | -3.46x |
| 2015-06-30 | -39.60x |
| 2015-03-31 | -16.98x |
| 2014-12-31 | -23.51x |
| 2014-09-30 | -5.09x |
| 2014-06-30 | -6.54x |
| 2014-03-31 | -21.37x |
| 2013-12-31 | -53.98x |
| 2013-09-30 | -14.86x |
| 2013-06-30 | -20.54x |
| 2013-03-31 | -50.42x |
| 2012-12-31 | -46.56x |
| 2012-09-30 | -16.36x |
| 2012-06-30 | -5.80x |
| 2012-03-31 | -10.75x |
| 2011-12-31 | 9.00x |
